Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor

NCT00458315 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped never been started

Conditions

Unknown Primary Tumors

Interventions

DRUG: Cisplatin
DRUG: Paclitaxel
DRUG: Gemcitabine
DRUG: Avastin (Bevacizumab)

Sponsor

Rigshospitalet, Denmark